State Street Corp Autolus Therapeutics PLC Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, State Street Corp holds 68,317 shares of AUTL stock, worth $146,881. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,317

Previous 256,515 73.37%

Holding current value

$146,881

Previous $397,000 60.96%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$1.14 - $2.4 $214,545 - $451,675	-188,198 Reduced 73.37%	68,317 $155,000
Q1 2025 May 15, 2025	SELL	$1.55 - $2.68 $23 - $40	-15 Reduced 0.01%	256,515 $397,000
Q4 2024 Feb 14, 2025	SELL	$2.18 - $4.8 $763,030 - $1.68 Million	-350,014 Reduced 57.71%	256,530 $602,000
Q3 2024 Nov 14, 2024	BUY	$3.38 - $4.69 $35,155 - $48,780	10,401 Added 1.74%	606,544 $2.2 Million
Q2 2024 Aug 14, 2024	BUY	$3.33 - $5.68 $1.83 Million - $3.13 Million	550,287 Added 1200.03%	596,143 $2.07 Million
Q1 2024 May 15, 2024	SELL	$5.39 - $7.29 $35,202 - $47,610	-6,531 Reduced 12.47%	45,856 $292,000
Q2 2023 Aug 14, 2023	SELL	$1.64 - $3.21 $80,130 - $156,840	-48,860 Reduced 48.26%	52,387 $124,000
Q1 2023 May 15, 2023	BUY	$1.75 - $2.25 $83,457 - $107,302	47,690 Added 89.05%	101,247 $186,000
Q4 2022 Feb 14, 2023	BUY	$1.74 - $3.27 $417 - $784	240 Added 0.45%	53,557 $101,000
Q3 2022 Nov 15, 2022	SELL	$2.04 - $3.76 $1,244 - $2,293	-610 Reduced 1.13%	53,317 $114,000
Q2 2022 Aug 15, 2022	SELL	$2.04 - $4.68 $36,664 - $84,113	-17,973 Reduced 25.0%	53,927 $153,000
Q1 2022 May 16, 2022	SELL	$3.52 - $5.46 $283,261 - $439,377	-80,472 Reduced 52.81%	71,900 $300,000
Q4 2021 Feb 14, 2022	BUY	$5.1 - $7.0 $524,310 - $719,642	102,806 Added 207.41%	152,372 $791,000
Q3 2021 Nov 15, 2021	BUY	$5.32 - $7.37 $146,550 - $203,021	27,547 Added 125.11%	49,566 $325,000
Q2 2021 Aug 16, 2021	SELL	$4.78 - $7.96 $2,461 - $4,099	-515 Reduced 2.29%	22,019 $146,000
Q4 2020 Feb 16, 2021	SELL	$8.13 - $12.79 $14,089 - $22,165	-1,733 Reduced 7.14%	22,534 $201,000
Q3 2020 Nov 10, 2020	BUY	$11.64 - $16.3 $151,308 - $211,883	12,999 Added 115.36%	24,267 $282,000
Q2 2020 Aug 14, 2020	SELL	$5.38 - $16.14 $3,098 - $9,296	-576 Reduced 4.86%	11,268 $181,000
Q1 2020 May 11, 2020	BUY	$4.2 - $13.0 $49,744 - $153,972	11,844 New	11,844 $71,000

Others Institutions Holding AUTL

# of Institutions

Shares Held

165M

Call Options Held

Put Options Held

39.3K

View Full List

About Autolus Therapeutics plc

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $195M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

More about AUTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Autolus Therapeutics PLC Transaction History